Novavax, Inc.

Grantee website Gaithersburg, Maryland, United States
Purpose
to advance to WHO Pre-Qualification the development of a respiratory syncytial virus (RSV) vaccine for maternal immunization to reduce the burden of RSV disease in infants less than six months of age in developing countries
Division
Global Health
Date
SEPTEMBER 2015
Region served
GLOBAL
Committed amount
$82,553,834
Grant topic
Pneumonia
Duration (months)
75
Grantee location
Gaithersburg, Maryland, United States

More about our work

Pneumonia

Our goal is to significantly reduce childhood deaths from pneumonia.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.